Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

A woman with multiple autoimmune diseases showed improvement in hair loss but not in skin discoloration after treatment.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Mouse models help understand alopecia areata and find treatments.

JAK inhibitors show promise as a future treatment for hair loss.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Topical corticosteroids can help treat severe alopecia areata when other treatments fail.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Alopecia areata's causes are unclear, treatments exist but relapses are common.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

An 8-year-old girl had nail and hair issues that improved without specific treatment, but fungal nail infection was hard to cure.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Omics techniques are needed to understand the scalp microbiome's role in alopecia areata for new treatments.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Treating stubborn hair loss involves both medical and emotional support options.